Class 514/966 - RECTAL

Subclass of Class 514 - Drug, bio-affecting and body treating compositions
No. of patents: 144
Last issue date: 09/23/2008

Browse patents
Browse applications

«First «Previous1 2 3 4 Next»Last»

Number	Title	Issue Date
7427416	Methods of treating conditions using metal-containing materials Methods of treating conditions using metal-containing materials are disclosed. Exemplary conditions include bacterial conditions, biofilm conditions, microbial conditions, inflammatory conditions, fungal conditions, viral conditions, autoimmune conditions, idiopathi...	09/23/2008
7419971	Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application Methods and compositions for enhancing the activity and/or duration of action of soft anti-inflammatory steroids of the haloalkyl 17α-alkoxy-11β-hydroxyandrost-4-en-3-one-17β-carboxylate type and the corresponding Δ1,4 compounds and of anti-inflammato...	09/02/2008
7344732	Medicated tampon A tampon adapted to deliver a therapeutic agent, the tampon including a tampon body that is manufactured at a first manufacturing facility; and a dosage form coupled to the body, wherein the dosage form includes a formulation including a therapeutic agent, and where...	03/18/2008
7341737	Medicated tampon A tampon adapted to deliver a therapeutic agent, the tampon including a tampon body having a distal end; and a dosage form affixed to the distal end of the tampon body, wherein the dosage form includes a formulation including a therapeutic agent, and wherein the dos...	03/11/2008
7255881	Metal-containing materials Metal-containing materials, as well as their preparation and use are disclosed. The metal-containing material can be, for example, an antimicrobial material, an anti-biofilm material, an antibacterial material, an anti-inflammatory material, an anti-fungal material,...	08/14/2007
7226622	Chemoablation of tissue using biodegradable, solid salt dosage forms Novel methods for the chemical ablation of tissue (e.g. prostatic tissue) are described. These methods include the steps of: (a) providing one or more solid salt dosage form comprising 50-100% w/w salt; and (b) inserting one or more of such solid salt dosage forms i...	06/05/2007
7087249	Treatment of mucosal membranes The invention relates to the use of one or more antimicrobial metals preferably selected from silver, gold, platinum, and palladium but most preferably silver, formed with atomic disorder, and preferably in a nanocrystalline form, for reducing inflammation or infect...	08/08/2006
7022335	Suppository of retaining in lower region of rectum A suppository of retaining in a lower region of rectum, which contains a suppository base containing: (A) a fatty acid triglyceride, (B) one or more C14-18 fatty acid glycerides, and (C) a base ingredient for retaini...	04/04/2006
6958159	Pharmaceutical gel composition The present invention relates to an improved pharmaceutical composition useful for the topical treatment of burns, cuts, wounds, abrasions and the like, and to methods of treatment of injured body surfaces such as skin. ...	10/25/2005
6740338	Reduced form of Cenzyme Q in high bioavailability stable oral dosage form The present invention relates to a reduced form of Coenzyme Q also known as ubiquinol in oral dosage form such as a gelatin capsule, preferably a soft gelatin capsule. Compositions according to the present invention include storage stable compositions comprising eff...	05/25/2004
6740333	Suppository and composition comprising at least one polyethylene glycol There is provided a suppository comprising at least one biocompatible polymer, wherein the biocompatible polymer is essentially non-biodegradable, and wherein the suppository essentially does not swell when contacted with an aqueous fluid. The suppository may furthe...	05/25/2004
6569883	Medicaments The invention relates to the use of compounds of the general formula (I) ##STR1## wherein R1 represents a hydrogen atom or a C1-10 alkyl, C3-7 cycloalkyl, C3-7 cycloalkyl-(C1-4)alkyl, C3-6 alken...	05/27/2003
6565850	Hemorrhoidal compositions and method of use The present invention is directed to gel compositions useful in the preparation of medicated gel products. Such medicated gel products are suitable for use in the treatment of anorectal disorders such as hemorrhoids. Also disclosed is a method for the tre...	05/20/2003
6488954	Liquid suppository composition of diclofenac sodium The present invention relates to a liquid suppository composition comprising diclofenac sodium, poloxamer and at least one polymer select from the group consisting of polyethylene oxide and polyvinylpyrrolidone. The composition provides the advantages of....	12/03/2002
6462083	Suppository base This invention provides a suppository base composition of erucic acid and beeswax with improved chemical stability, moldability, and shelf-life. The inventive suppository base also stimulates localized blood flow to the administration site....	10/08/2002
6437006	Pharmaceutical carrier formulation This invention provides carrier systems useful in preparing pharmaceutical formulations, the systems comprising, by weight percentage, from about 1% to about 20%, preferably from about 5% to about 12%, of a surfactant component; from about 55% to about 93...	08/20/2002
6432935	Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients Compositions comprising an antibiotic, sulphonamide, at least one an antiquagul agent, e.g., clotrimazol (bis-phenyl-(2-chlorophenyl)-1-imidazolyl-methane), natamycin, or nystatin,and 5-nitro-metronidazol (5-nitro-inidazoles) e.g., (metronidazol or t...	08/13/2002
6326023	Synergistic anti-malarial formulation The present invention relates to a synergistic formulation comprising pharmaceutically effective amount of ଱/ଲ arteether and a neutralized refined vegetable oil suitable for administration by rectal route, method for the treatment of cerebral ...	12/04/2001
6326401	Formulation for the oromucosal, in particular pernasal, route A liquid pharmaceutical formulation for administration by the oro-mucosal route, comprising at least one non-polypeptidic active substance and less than 5% W/W of capryl caproyl macrogol glycerides, process for its preparation and it uses....	12/04/2001
6322820	Composition of matter and method for the relief of hemorrhoidal conditions A composition of matter for treating hemorrhoids comprising a pharmaceutically acceptable carrier, between 1% and 10% by weight of zinc oxide, between 0.2% and 5% by weight of resorcinol and between 0.1% and 3% by weight of menthol. A preferred carrier is...	11/27/2001
6277396	Dietary supplement containing a thermogenic substance and an adrenal support substance A dietary supplement system having a daytime component and a nighttime component is provided, wherein the daytime component comprises at least one thermogenic substance and the nighttime component comprises at least one adrenal support substance....	08/21/2001
6270789	Base for suppository The present invention provides a base for suppository comprising oily or fatty base and polyethlene. The suppository prepared by the use of the base of the present invention has superior heat resistance which should not cause quality deterioration such as...	08/07/2001
6242010	Synergistic antioxidant compositions in management of hemorrhoids and other ano-rectal inflammatory conditions Compositions for remediating ano-rectal inflammatory processes, hemorrhoidal syndromes and ano-rectal wounds. The composition includes the synergistic combination of reduced glutathione and selenium as a selenoamino acid in a suitable carrier for topical ...	06/05/2001
6221401	Bilayer structure which encapsulates multiple containment units and uses thereof The present invention provides a bilayer structure for encapsulating multiple containment units. These containment units can attach or contain therapeutic or diagnostic agents that can be released through the bilayer structure. A suitable example of such ...	04/24/2001
6200557	Method of treating HIV by a topical composition A solution or gel composition containing activated stabilized chlorine dioxide and phosphates, such as disodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, and sodium monofluorophosphate, is disclosed for destroying HIV. The pref...	03/13/2001
6153217	Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents A process for producing a small-sized, lipid-based cochleate is described. Cochleates are derived from liposomes which are suspended in an aqueous two-phase polymer solution, enabling the differential partitioning of polar molecule based-structure by phas...	11/28/2000
6136334	Medical uses of in situ formed gels Balanced pH, hyperosmotic, hypoosmotic, or isoosmotic gels are ideal vehicles for drug delivery. They are especially suited for topical body cavity or injection application of drugs or diagnostic agents; for drug or diagnostic agent delivery to the eye of...	10/24/2000
6136337	Long-lasting composition for rectal administration There is provided a composition for rectal administration suitable for curing hemorrhoids or the like by which the concentration of a medicine in the affected tissue is increased and the potency of the medicine is expected to continue. The long acting com...	10/24/2000
6123961	Treating urinary incontinence with (R)-desethyloxybutynin and (R)-oxybutynin A method for treating or preventing urinary incontinence and other motility disorders involving the urethrogenital tract, by administering to a mammal an effective amount of the R-isomers of 4-diethylamino-2-butynyl cyclohexylphenylglycolate and 4-ethylam...	09/26/2000
6121329	Topical administration of 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol An external preparation for topical administration which aims at inhibiting rejection reactions at organ or bone marrow transplantation or treating autoimmune diseases or allergic diseases and contains as the active ingredient 2-amino-2-(2-(4-octylphenyl)...	09/19/2000
6106864	Pharmaceutical formulations containing darifenacin There is provided a pharmaceutical dosage form adapted for administration to the gastrointestinal tract of a patient, comprising darifenacin, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable adjuvant, diluent or carrier, ch...	08/22/2000
6060060	Analgesic compositions from sweet peppers and methods of use thereof This invention relates to analgesic compositions obtained from the fruit of the Capsicum genus, in particular Capsicum annuum and more particularly to purees or extracts of sweet peppers. This invention further relates to therapeutic uses of such analgesi...	05/09/2000
6017554	Composition for treating abnormal conditions of the epithelium of bodily orifices A stable solution cream, salve, or spray composition containing activated stabilized chlorine dioxide and phosphates, such as disodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, and sodium monofluorophosphate, is disclosed for t...	01/25/2000
5994383	Surfactant-based antimicrobial compositions and methods for using the same Antimicrobial compositions and methods for preparing and using same are provided. The antimicrobial compositions are surfactant-based and contain certain benzalkonium chloride homologs. The compositions are useful in treating infections in animals and hum...	11/30/1999
5958443	Medical uses of in situ formed gels Balanced pH, hyperosmotic, hypoosmotic, or isoosmotic gels are ideal vehicles for drug delivery. They are especially suited for topical body cavity or injection application of drugs or diagnostic agents; for drug or diagnostic agent delivery to the eye of...	09/28/1999
5935592	Method for treating vaginitis and endometriosis A stable solution, cream, salve, or spray composition containing activated chlorine dioxide and phosphates, such as disodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, and sodium monofluorophosphate, is disclosed for the treatme...	08/10/1999
5902575	Method for treating the epithelium of bodily orifices with chlorine dioxide and a phosphate compound A stable solution, cream, salve, or spray composition containing chlorine dioxide and a phosphate, such as disodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, and sodium monofluorophosphate, is disclosed for the prevention and t...	05/11/1999
5834003	Method for oxidatively consuming volatile sulfur compounds at bodily orifices A method for oxidatively consuming volatile sulfur compounds selected from the group consisting of dimethylsulfide, hydrogen sulfide, and methylmercaptan at the epithelial barrier of the rectal, vaginal, urethral, oral, nasal, ocular, and auditory canal o...	11/10/1998
5811115	Composition for treating abnormal conditions of the epithelium of bodily orifices A stable solution, cream, salve, or spray composition containing chlorine dioxide and phosphates, such as disodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, and sodium monofluorophosphate, is disclosed for the prevention and tr...	09/22/1998
5719122	Pharmaceutical compositions containing a calcitonin Pharmaceutical compositions comprising a calcitonin and a polyglycolysed glyceride and a method of enhancing the transdermal or transmucosal absorption of calcitonin in a mammal are disclosed....	02/17/1998

«First «Previous1 2 3 4 Next»Last»

PatentStorm

Bizarre Patents

PatentStorm News

Class 514/966 - RECTAL